PubRank

Scott L Nyberg

Author PubWeight™ 52.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute liver failure: Summary of a workshop. Hepatology 2008 3.49
2 Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004 1.79
3 A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 2007 1.70
4 Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007 1.64
5 Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant 2011 1.51
6 Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006 1.43
7 Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 2009 1.41
8 Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004 1.34
9 MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004 1.34
10 Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003 1.29
11 Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004 1.29
12 Cell therapies for liver diseases. Liver Transpl 2012 1.24
13 Artificial and bioartificial liver support. Semin Liver Dis 2008 1.21
14 Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004 1.17
15 Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging 2011 1.10
16 Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004 1.05
17 E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant 2009 1.04
18 ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003 1.04
19 Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004 1.01
20 Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res 2012 1.00
21 Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg 2012 0.99
22 Living donor liver transplantation using a right lobe graft in an adult with situs inversus. Liver Transpl 2005 0.97
23 Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology 2011 0.97
24 Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 2002 0.94
25 In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs. Liver Transpl 2013 0.91
26 Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res 2012 0.89
27 Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids. Cell Transplant 2012 0.89
28 Membrane pore size impacts performance of a xenogeneic bioartificial liver. Transplantation 2003 0.88
29 Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford) 2014 0.88
30 Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg 2013 0.87
31 Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function. J Cell Physiol 2011 0.87
32 United Network for Organ Sharing's expanded criteria donors: is stratification useful? Clin Transplant 2005 0.86
33 Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis 2012 0.85
34 Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant Rev (Orlando) 2008 0.85
35 Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int 2004 0.84
36 Decline in native renal function early after bladder-drained pancreas transplantation alone. Transplantation 2004 0.83
37 Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. Biotechnol Bioeng 2009 0.83
38 Apoptotic cell death and function of cryopreserved porcine hepatocytes in a bioartificial liver. Cell Transplant 2003 0.81
39 Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation 2004 0.80
40 Engineering analysis and development of the spheroid reservoir bioartificial liver. Conf Proc IEEE Eng Med Biol Soc 2009 0.79
41 Extracorporeal treatment of acute liver failure. Hepatol Res 2008 0.78
42 Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transpl 2015 0.78
43 Keratin, fas, and cryptogenic liver failure. Liver Transpl 2002 0.78
44 Gene expression and functional analyses of primary rat hepatocytes on nanofiber matrices. Cells Tissues Organs 2009 0.78
45 Routine use of livers from deceased donors older than 70: is it justified? Transpl Int 2005 0.78
46 Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery 2002 0.78
47 Suspension culture of hepatocyte-derived reporter cells in presence of albumin to form stable three-dimensional spheroids. Biotechnol Bioeng 2013 0.77
48 Improving utilization of deceased donor kidneys by matching recipient and graft survival. Transplantation 2006 0.77
49 Cell therapy in chronic liver disease. Curr Opin Gastroenterol 2016 0.75
50 What's the score? Clin Transplant 2004 0.75
51 Cold storage of rat hepatocyte spheroids. Cell Transplant 2013 0.75
52 Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts. Cells Tissues Organs 2017 0.75
53 Late presentation of pylephlebitis after orthotopic liver transplantation. Liver Transpl 2003 0.75
54 Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts. Cells Tissues Organs 2016 0.75
55 EXTRACORPOREAL APPLICATION OF A GEL-ENTRAPMENT, BIOARTIFICIAL LIVER: DEMONSTRATION OF DRUG METABOLISM AND OTHER BIOCHEMICAL FUNCTIONS. Cell Transplant 1993 0.75
56 Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score. Ethn Dis 2008 0.75
57 Treatment of persistent/medically refractory covert hepatic encephalopathy with the molecular adsorbent recirculating system. Liver Transpl 2014 0.75